We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$2.21B
AUM Growth
+$67.4M
Cap. Flow
+$120M
Cap. Flow %
5.45%
Top 10 Hldgs %
16.34%
Holding
918
New
52
Increased
475
Reduced
305
Closed
67

Top Buys

Rank Stock Value
1
VTV icon
Vanguard Morningstar Value ETF
VTV
+$20.8M
2
ISPY icon
ProShares S&P 500 High Income ETF
ISPY
+$7.79M
3
IGEB icon
iShares Investment Grade Systematic Bond ETF
IGEB
+$6.89M
4
PFFD icon
Global X US Preferred ETF
PFFD
+$5.59M
5
MHD icon
BlackRock MuniHoldings Fund
MHD
+$5.14M

Top Sells

Rank Stock Value
1
JQUA icon
JPMorgan US Quality Factor ETF
JQUA
+$23.8M
2
NAD icon
Nuveen Quality Municipal Income Fund
NAD
+$4.23M
3
INSM icon
Insmed
INSM
+$3.13M
4
NAN icon
Nuveen New York Quality Municipal Income Fund
NAN
+$2.67M
5
NRK icon
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
+$2.62M

Sector Composition

Rank Sector Weight
1 Technology 12.03%
2 Healthcare 10.7%
3 Financials 10.61%
4 Industrials 5.55%
5 Consumer Discretionary 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLP icon
451
Simulations Plus
SLP
$370M
$1.07M 0.05%
38,259
-285
-0.7% -$8.67K
FISV
452
Fiserv Inc
FISV
$28B
$1.07M 0.05%
5,192
+325
+7% +$66.3K
WFC icon
453
Wells Fargo
WFC
$264B
$1.07M 0.05%
15,183
+3,905
+35% +$267K
DCO icon
454
Ducommun
DCO
$2.98B
$1.07M 0.05%
16,736
+5,554
+50% +$357K
PCRX icon
455
Pacira BioSciences
PCRX
$972M
$1.06M 0.05%
56,385
+8,636
+18% +$152K
HEI icon
456
HEICO Corp
HEI
$51.3B
$1.06M 0.05%
4,444
+1,355
+44% +$351K
LHX icon
457
L3Harris
LHX
$53.3B
$1.04M 0.05%
4,963
+1,501
+43% +$360K
LUNR icon
458
Intuitive Machines
LUNR
$2.64B
$1.04M 0.05%
57,463
+33,939
+144% +$376K
MANH icon
459
Manhattan Associates
MANH
$11.4B
$1.04M 0.05%
3,850
-39
-1% -$11.1K
GILD icon
460
Gilead Sciences
GILD
$168B
$1.04M 0.05%
11,237
-5,633
-33% -$507K
MELI icon
461
Mercado Libre
MELI
$98.4B
$1.04M 0.05%
609
+51
+9% +$99.3K
BBIO icon
462
BridgeBio Pharma
BBIO
$16.4B
$1.03M 0.05%
37,659
-384
-1% -$9.92K
SJM icon
463
J.M. Smucker
SJM
$12.5B
$1.02M 0.05%
9,274
+825
+10% +$94.9K
J icon
464
Jacobs Solutions
J
$17.3B
$1.01M 0.05%
7,647
-196
-2% -$27K
HYDB icon
465
iShares High Yield Systematic Bond ETF
HYDB
$1.6B
$1.01M 0.05%
21,462
+3,932
+22% +$187K
GGG icon
466
Graco
GGG
$13.5B
$1.01M 0.05%
11,939
+2,328
+24% +$202K
HVT icon
467
Haverty Furniture Companies
HVT
$443M
$1.01M 0.05%
45,179
-14,555
-24% -$345K
HTD
468
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$902M
$972K 0.04%
44,119
-8,161
-16% -$187K
ETG
469
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.86B
$968K 0.04%
53,111
+6,877
+15% +$131K
SEIC icon
470
SEI Investments
SEIC
$12.6B
$967K 0.04%
11,722
+1,961
+20% +$154K
BSJQ icon
471
Invesco BulletShares 2026 High Yield Corporate Bond ETF
BSJQ
$866M
$966K 0.04%
41,502
-21,910
-35% -$513K
PFE icon
472
Pfizer
PFE
$152B
$964K 0.04%
36,334
-3,253
-8% -$88.2K
PROK icon
473
ProKidney
PROK
$330M
$961K 0.04%
+568,647
New +$1.03M
INTA icon
474
Intapp
INTA
$3.08B
$960K 0.04%
14,974
-21
-0.1% -$1.2K
APLS
475
DELISTED
Apellis Pharmaceuticals
APLS
$949K 0.04%
29,740
+17,115
+136% +$515K
17 18
19
20 21

Similar funds

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
DILIC
Dai-ichi Life Insurance Company Tokyo, Japan $3.49B AUM 27.28% 1-Year Est. Return
TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
ACM
Aquatic Capital Management Chicago, Illinois $3.48B AUM 24.9% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Hennion & Walsh Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Hennion & Walsh Asset Management held 918 positions worth $2.21B, up 3.1% from $2.14B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hennion & Walsh Asset Management deployed $120M of net new capital in Q4 2024, opening 52 new positions and adding to 475 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 118,596 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was JPMorgan US Quality Factor ETF, an estimated $23.8M trimmed.

  • Hennion & Walsh Asset Management's largest Q4 2024 buy was Vanguard Morningstar Value ETF: 118,596 shares worth $20.1M.
  • Hennion & Walsh Asset Management added most to ProShares S&P 500 High Income ETF in Q4 2024, an estimated $7.79M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2024 reduction was JPMorgan US Quality Factor ETF, cutting an estimated $23.8M.
  • Hennion & Walsh Asset Management fully exited MorphoSys AG American Depositary Shares in Q4 2024, selling an estimated $2.34M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 16% of its $2.21B portfolio in Q4 2024.
  • Hennion & Walsh Asset Management opened 52 new positions and closed 67 in Q4 2024.
  • Hennion & Walsh Asset Management's portfolio value rose 3.1% quarter-over-quarter to $2.21B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2024, filed 15 Jan 2025.